← Search & browse all drugs
CARDIOVASCULAR SYSTEM › LIPID MODIFYING AGENTS › LIPID MODIFYING AGENTS, PLAIN › Other lipid modifying agents
bempedoic acid
C10AX15
Forms & Strengths
- Tablet: 180mg
- Film-coated tablets
Adult Dosing
- Initial dose: 180mg once daily
- Maximum dose: 180mg once daily
- Dose adjustment for patients with hepatic impairment: not necessary
Pediatric Dosing
- Safety and efficacy not established in pediatric patients
- Not recommended for use in patients under 18 years
Indications
- As an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia or established atherosclerotic cardiovascular disease
- To reduce low-density lipoprotein cholesterol (LDL-C) levels
Mechanism of Action
- Inhibits ATP-citrate lyase, a key enzyme in the cholesterol biosynthesis pathway
- Reduces cholesterol production in the liver
Contraindications
- Hypersensitivity to bempedoic acid or any component of the formulation
- Severe hepatic impairment
Adverse Reactions
- Most common: upper respiratory tract infection, musculoskeletal pain, fatigue, hyperuricemia
- Less common: increased serum creatinine, elevated liver enzymes, rash
Drug Interactions
- Concomitant use with simvastatin increases risk of myopathy
- May increase international normalized ratio (INR) when co-administered with warfarin
Curated Content: Needs Vetting Before Put to Clinical Use